Furthermore, immunohistochemical staining of ATM and p53 in pancreatic tumor samples reveal that tumoral loss of ATM with wild-type p53 correlates with a decrease in patient survival, especially in families with a history of pancreatic cancer (25). This evidence concerns the gene ATM and pancreatic neoplasm.